Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Dec 16, 16:00
Sinovac Biotech EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | -0.55 |
| Zai Lab Ltd | -0.40 |
| China SXT Pharmaceuticals Inc | -- |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -0.1565 |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | -6.942B |
| Earnings Yield | -20.25% |
| Normalized Earnings Yield | -10.50 |